130 related articles for article (PubMed ID: 7378171)
21. [The role of the culture medium in the sensitivity of Gram-negative stocks and their resistant mutants to fosfomycin. The influence of glucose-6-phosphate].
Drugeon H; Courtieu AL
Minerva Med; 1978 Dec; 69(59):4055-60. PubMed ID: 105326
[No Abstract] [Full Text] [Related]
22. Studies on phosphonic acid antibiotics. IV. Synthesis and antibacterial activity of analogs of 3-(N-acetyl-N-hydroxyamino)-propylphosphonic acid (FR-900098).
Hemmi K; Takeno H; Hashimoto M; Kamiya T
Chem Pharm Bull (Tokyo); 1982 Jan; 30(1):111-8. PubMed ID: 7083400
[No Abstract] [Full Text] [Related]
23. Susceptibility of multiresistant serotype 012 Pseudomonas aeruginosa to fosfomycin in combination with other antibiotics.
Watine J; Bourrel C; Dubourdieu B; Gineston JL; Bories P; Durand M; Marre A; Formosa F; Brunel MP; Palliez J
Pathol Biol (Paris); 1994 Apr; 42(4):293-5. PubMed ID: 7808781
[TBL] [Abstract][Full Text] [Related]
24. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
Hara T; Araake M; Watabe H
Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
[TBL] [Abstract][Full Text] [Related]
25. Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.
Shimizu M; Shigeobu F; Miyakozawa I; Nakamura A; Suzuki M; Mizukoshi S; O'Hara K; Sawai T
Antimicrob Agents Chemother; 2000 Jul; 44(7):2007-8. PubMed ID: 10970248
[No Abstract] [Full Text] [Related]
26. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
[TBL] [Abstract][Full Text] [Related]
27. Reevaluation of fosfomycin: clinical and laboratory studies.
Dai ZY; Zhang YY; Zhang MF; Zhang ZL; Zhang JD; Liu YK
Chin Med J (Engl); 1981 Oct; 94(10):645-52. PubMed ID: 6797798
[No Abstract] [Full Text] [Related]
28. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
Dette GA; Knothe H; Schönenbach B; Plage G
J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
[TBL] [Abstract][Full Text] [Related]
29. Evolution of bacterial sensitivity to fosfomycin in the Cindad Sanitaria 'Francisco Franco' in Barcelona.
Crespo E; Roca de Viñals JA
Chemotherapy; 1977; 23 Suppl 1():112-6. PubMed ID: 401716
[TBL] [Abstract][Full Text] [Related]
30. Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.
Alés JM
Chemotherapy; 1977; 23 Suppl 1():94-8. PubMed ID: 401722
[TBL] [Abstract][Full Text] [Related]
31. [Antimicrobial activity of fosfomycin under various conditions against standard strains, beta-lactam resistant strains, and multidrug efflux system mutants].
Mikuniya T; Hiraishi T; Maebashi K; Ida T; Takata T; Hikida M; Yamada S; Gotoh N; Nishino T
Jpn J Antibiot; 2005 Apr; 58(2):105-22. PubMed ID: 15997654
[TBL] [Abstract][Full Text] [Related]
32. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies.
Falagas ME; Kastoris AC; Karageorgopoulos DE; Rafailidis PI
Int J Antimicrob Agents; 2009 Aug; 34(2):111-20. PubMed ID: 19403273
[TBL] [Abstract][Full Text] [Related]
33. Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates.
Fonseca MRB; Sato JL; Lima-Noronha MA; Migliorini LB; Fernández-Silva FS; Galhardo RS
Infect Genet Evol; 2018 Mar; 58():27-33. PubMed ID: 29248795
[TBL] [Abstract][Full Text] [Related]
34. Fosfomycin: Laboratory studies.
Woodruff HB; Mata JM; Hernández S; Mochales S; Rodríguez A; Stapley EO; Wallick H; Miller AK; Hendlin D
Chemotherapy; 1977; 23 Suppl 1():1-22. PubMed ID: 583866
[TBL] [Abstract][Full Text] [Related]
35. Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium.
Cordaro JC; Melton T; Stratis JP; Atagün M; Gladding C; Hartman PE; Roseman S
J Bacteriol; 1976 Dec; 128(3):785-93. PubMed ID: 186449
[TBL] [Abstract][Full Text] [Related]
36. [Assessment of 2 automated microdilution techniques compared to an agar dilution method in determining sensitivity to fosfomycin in strains of carbapenem-resistant Pseudomonas aeruginosa].
Gil-Romero Y; Regodón-Domínguez M; Wilhelmi de Cal I; López-Fabal F; Gómez-Garcés JL
Enferm Infecc Microbiol Clin; 2016; 34(7):406-8. PubMed ID: 26620604
[TBL] [Abstract][Full Text] [Related]
37. Fosfomycin and plasmidic resistance.
Baquero F; López-Brea M; Valls A; Cañedo T
Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
Pruekprasert P; Tunyapanit W
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
[TBL] [Abstract][Full Text] [Related]
39. Evolution of sensitivity to fosfomycin in bacteria isolated in 1973, 1974 and 1975 in the Servicio de Microbiologia y Epidemiologia of the 'Clinica Puerta de Hierro', Madrid.
Dámaso D; Moreno-López M; Martínez-Beltrán J
Chemotherapy; 1977; Suppl 1():104-11. PubMed ID: 832509
[TBL] [Abstract][Full Text] [Related]
40. Activity of fosfomycin and R-plasmid conferring fosfomycin resistance among some clinical bacteria isolates in Nigeria.
Obaseiki-Ebor EE
Chemotherapy; 1986; 32(1):31-6. PubMed ID: 3081302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
